4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine
C74H99F3N16O4 — CID 158881650
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine
4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine (PubChem CID 158881650) has the molecular formula C74H99F3N16O4 and a molecular weight of 1333.71 g/mol. Its IUPAC name is 4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine.
Molecular Properties
| Compound Name | 4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine |
|---|---|
| PubChem CID | 158881650 |
| Molecular Formula | C74H99F3N16O4 |
| Molecular Weight | 1333.71 g/mol |
| Exact Mass | 1332.80 |
| IUPAC Name | 4-[2-[[(2S)-1-methoxypropan-2-yl]amino]-5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclohexan-1-ol;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-1-propan-2-yloxypropan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine;7-(4-methylcyclohexyl)-5-(2-methyl-4-pyridinyl)-N-[(2S)-4,4,4-trifluorobutan-2-yl]pyrrolo[2,1-f][1,2,4]triazin-2-amine |
| SMILES | COC[C@H](C)Nc1ncc2c(-c3cncc(CN4CCOCC4)c3)cc(C3CCC(O)CC3)n2n1.Cc1cc(-c2cc(C3CCC(C)CC3)n3nc(N[C@@H](C)CC(F)(F)F)ncc23)ccn1.Cc1cc(-c2cc(C3CCC(C)CC3)n3nc(N[C@@H](C)COC(C)C)ncc23)ccn1 |
| InChI | InChI=1S/C26H36N6O3.C25H35N5O.C23H28F3N5/c1-18(17-34-2)29-26-28-15-25-23(12-24(32(25)30-26)20-3-5-22(33)6-4-20)21-11-19(13-27-14-21)16-31-7-9-35-10-8-31;1-16(2)31-15-19(5)28-25-27-14-24-22(21-10-11-26-18(4)12-21)13-23(30(24)29-25)20-8-6-17(3)7-9-20;1-14-4-6-17(7-5-14)20-11-19(18-8-9-27-15(2)10-18)21-13-28-22(30-31(20)21)29-16(3)12-23(24,25)26/h11-15,18,20,22,33H,3-10,16-17H2,1-2H3,(H,29,30);10-14,16-17,19-20H,6-9,15H2,1-5H3,(H,28,29);8-11,13-14,16-17H,4-7,12H2,1-3H3,(H,29,30)/t18-,20?,22?;17?,19-,20?;14?,16-,17?/m000/s1 |
| InChIKey | JDCGNGGALUJKJA-GXGFMBKESA-N |
| XLogP | 14.85 |
| TPSA | 216.49 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 97 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1333.71 |
| LogP ≤ 5 | 14.85 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158881650 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.